Life Sciences Manufacturer to Expand in Florida & Add 72 Employees
02/10/2012
CEO Scott Sensenbrenner said the project's scope will include the expansion of lab, office space and production areas. He estimates the investment will exceed $850,000.
The firm also plans to add 72 employees to its current 50-person workforce over the next five years, according to Mark Huey, president and CEO of the EDC of Sarasota County. Those new jobs will include R&D, production, customer service, sales and other similar positions.
Founded in Florida in 1998, Enzymedica researches, develops, manufactures and distributes targeted enzyme supplements made from plant-based enzymes. Its dietary supplements support a wide array of indications, including digestive health, food intolerance, cardiovascular, immune, weight loss and other supportive functions.
"Our new facility, which we hope will be operational by September, is centrally located for the majority of our employees, and provides easy access from Interstate 75," explained Sensenbrenner. "We hope to attract top talent in the region."
The company has qualified for various performance-based incentives, including $216,000 from the state and an equal match from the Sarasota County government.
Project Announcements
Modus21 Expands North Charleston, South Carolina, Operations
12/10/2025
Lexington Manufacturing Plans Prineville, Oregon, Manufacturing Operations
12/10/2025
NOOTER Establishes Perrysburg, Ohio, Operations
12/10/2025
Cornerstone Building Brands Expands Rocky Mount, Virginia, Production Operations
12/10/2025
BWC Terminals Plans Pascagoula, Mississippi, Terminal Operations
12/10/2025
Farm Plast Plans Muncy, Pennsylvania, Manufacturing Operations
12/09/2025
Most Read
-
Rethinking Local Governments Through Consolidation and Choice
Q3 2025
-
First Person: Filter King’s Expansion Playbook
Q3 2025
-
Lead with Facts, Land the Deal
Q3 2025
-
How Canada Stays Competitive
Q3 2025
-
America’s Aerospace Reboot
Q3 2025
-
The Permit Puzzle and the Path to Groundbreaking
Q3 2025
-
2025’s Top States for Business: How the Winners Are Outpacing the Rest
Q3 2025